Manalo, Arlyn .

HRN: 01-61-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
CEFUROXIME 500MG (TAB)
03/29/2024
04/04/2024
PO
500mg
BID
Sp Rmle
Waiting Final Action 
03/30/2024
CEFUROXIME 1.5GM (VIAL)
03/30/2024
04/02/2024
IV
1.5g
Q8 X 3 Days
Wbc: 31.9; S/p NSVD With RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: